Ave Maria Biotechnology's Unattributed - IV Round

Ave Maria Biotechnology raised a round of funding on February 24, 2016.

Ave Maria Biotechnology (AVB) is dedicated to the discovery, development and commercialization of safe, effective and ethical stem cell technologies for regenerative medicine, oncology and fully human…

Articles about Ave Maria Biotechnology's Unattributed - IV Round: